Leiden, The Netherlands, 12 October 2023 – VarmX, a biotech company focusing on the development of innovative approaches for the reversal of anticoagulation, today announces that Dr. Jeffrey Lawson, currently the Company’s Chief Scientific Officer, will assume the role of CEO, succeeding Dr. Jan Öhrström who will continue as Chairman. Dr. Lawson, who is based in … Continue reading VarmX Promotes CSO Dr. Jeffrey Lawson to New CEO and Moves to New State-of-the-Art Facility